The first patient has been enrolled in WIND-PSC, a global study to track the natural course of primary sclerosing…
Articles by Margarida Maia, PhD
Note: This story was updated July 9, 2024, to clarify Livmarli is approved in the U.S. for all PFIC forms,…
The HealthWell Foundation, a charity that helps people who can’t afford to pay their medical bills, has started a…
Two scores calculated from blood biomarkers can accurately discriminate between pregnant women with intrahepatic cholestasis of pregnancy (ICP) and…
A toddler boy with cirrhosis, or permanent liver scarring, due to Alagille syndrome developed a hepatoblastoma, a type of…
A Phase 2a clinical trial testing Kezar Life Sciences’ investigational therapy zetomipzomib in adults with autoimmune hepatitis who did…
Researchers in China have identified five new mutations in the NR1H4 gene in three boys with progressive familial intrahepatic…
Combining ursodeoxycholic acid (UDCA) with elafibranor, an experimental oral therapy for primary biliary cholangitis (PBC), may be the best…
The U.S. Food and Drug Administration (FDA) has granted fast track designation to LB-P8, LISCure Biosciences’ experimental live bacterium…
Brain scans have shown children with neonatal cholestasis tend to have brain abnormalities, a review study found. Bleeding was…